跳至主要内容
临床试验/CTRI/2024/12/078553
CTRI/2024/12/078553已完成不适用

A open label, clinical study to evaluate the efficacy and safety of hair removal spray on healthy adult subjects

Pontika Aerotech Limited1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年1月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
1. Hair count reduction in the applied area by comparing with Photographs.

研究概览

简要总结

·        Study Objective: To evaluate the efficacy, safety, and tolerability of a hair removal spray.

·        Study Design:

ü  30 participants (15 males, 15 females)

ü  Hair removal spray applied for 8-10 minutes, followed by depilation.

ü   24-hour follow-up to assess efficacy and allergic reactions.

ü  Outcome Measurement Timeline: 24-hour follow-up after product use.

·        Primary Outcome Measures:

1.               Hair count reduction by photographic comparison.

2.               Subject comfort assessed using a VAS scale.

3.               Satisfaction with hair removal and improvement using a 10-point scale.

4.               Skin irritation (erythema and edema) evaluated via Draize’s scale.

5.               Product application feedback: ease of use, stickiness, greasiness, spreading, fragrance preferences.

·    secondary Outcomes Measures   :

1.               Monitoring of adverse events and serious adverse events during the study.

2.               Brief clinical examination for allergic reactions or irritations.

·        Participant Criteria:

1.               Inclusion:

§  Healthy adults aged 18-60.

§  Moderate hair growth on forearm, legs, and pubic area.

§  No cuts, marks, or open wounds.

§  No use of similar products in the last 4 weeks.

2.               Exclusion:

§  Pre-existing dermatologic conditions (e.g., psoriasis, eczema).

§  Vulnerable groups (children, elderly >80, mentally challenged).

§  Known allergies or sensitivities to cosmetic products or its ingredients.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • •Subjects in generally good health
  • •Subjects in the age group of 18-60 years.
  • •Subjects with moderate hair growth on forearm, legs and pubic area.
  • •Subjects without any cuts, marks and open wounds on forearm, legs and pubic area.
  • •Subjects have not used a similar product for the last four weeks.

排除标准

  • •Subjects who have pre-existing or dormant dermatologic conditions (e.g., psoriasis, rosacea, rashes, eczema and severe excoriations).
  • •Subjects with known allergies or sensitivities to cosmetic products, toiletries or its components like fragrances, preservatives, etc.
  • •History of allergy to the test product.

结局指标

主要结局

1. Hair count reduction in the applied area by comparing with Photographs.

时间窗: Visit 1 (day 1) and visit 2 (Day 2)

2. Subjects assessment of comfort associated with treatments using a VAS scale. Subjects satisfaction with hair removal treatments and assessment of improvement using a ten point scale.

时间窗: Visit 1 (day 1) and visit 2 (Day 2)

3. The skin will be evaluated for signs of irritation identified under Erythema and odema, using Draizes scale.

时间窗: Visit 1 (day 1) and visit 2 (Day 2)

4. a. Ease of application or usage b. Stickiness c. Greasiness and d. Ease of spreading.

时间窗: Visit 1 (day 1) and visit 2 (Day 2)

5. Product evaluation and product performance feedback questions will be obtained from the participants.

时间窗: Visit 1 (day 1) and visit 2 (Day 2)

次要结局

  • To demonstrate safety and tolerability of study product by Clinical AEs (If any)

研究者

发起方
Pontika Aerotech Limited
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Sakthi Balan

DK Elite Health Care Centre

研究点 (1)

Loading locations...

相似试验